These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8514849)

  • 1. Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus.
    Vestergaard H; Lund S; Larsen FS; Bjerrum OJ; Pedersen O
    J Clin Invest; 1993 Jun; 91(6):2342-50. PubMed ID: 8514849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and posttranslational upregulation of muscle-specific glycogen synthase in athletes.
    Vestergaard H; Andersen PH; Lund S; Schmitz O; Junker S; Pedersen O
    Am J Physiol; 1994 Jan; 266(1 Pt 1):E92-101. PubMed ID: 8304448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients.
    Vestergaard H; Bjørbaek C; Andersen PH; Bak JF; Pedersen O
    Diabetes; 1991 Dec; 40(12):1740-5. PubMed ID: 1756915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms.
    Henry RR; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Park KS; Nikoulina SE
    J Clin Invest; 1996 Sep; 98(5):1231-6. PubMed ID: 8787686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism.
    Mandarino LJ; Wright KS; Verity LS; Nichols J; Bell JM; Kolterman OG; Beck-Nielsen H
    J Clin Invest; 1987 Sep; 80(3):655-63. PubMed ID: 2957389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased concentrations of glycogen synthase protein in skeletal muscle of patients with NIDDM.
    Löfman M; Yki-Järvinen H; Parkkonen M; Lindström J; Koranyi L; Schalin-Jäntti C; Groop L
    Am J Physiol; 1995 Jul; 269(1 Pt 1):E27-32. PubMed ID: 7631777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
    Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
    J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
    Vestergaard H; Lund S; Bjørbaek C; Pedersen O
    Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia.
    Nikoulina SE; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Park KS; Henry RR
    Diabetes; 1997 Jun; 46(6):1017-24. PubMed ID: 9166674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM.
    Schalin-Jäntti C; Härkonen M; Groop LC
    Diabetes; 1992 May; 41(5):598-604. PubMed ID: 1568529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity.
    Suh KI; Murata C; Song YM; Joyce M; Gumbiner B; Ditzler TM; Henry RR
    J Clin Endocrinol Metab; 1993 Aug; 77(2):464-70. PubMed ID: 8345053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.
    Vaag A; Henriksen JE; Beck-Nielsen H
    J Clin Invest; 1992 Mar; 89(3):782-8. PubMed ID: 1541672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
    Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
    Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations.
    Vaag AA; Handberg A; Skøtt P; Richter EA; Beck-Nielsen H
    Eur J Endocrinol; 1994 Jan; 130(1):70-9. PubMed ID: 8124481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.
    Mandarino LJ; Consoli A; Kelley DE; Reilly JJ; Nurjhan N
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1544-51. PubMed ID: 2121778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.
    Thorburn AW; Gumbiner B; Bulacan F; Wallace P; Henry RR
    J Clin Invest; 1990 Feb; 85(2):522-9. PubMed ID: 2105341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients.
    Yki-Järvinen H; Sahlin K; Ren JM; Koivisto VA
    Diabetes; 1990 Feb; 39(2):157-67. PubMed ID: 2121571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.
    Del Prato S; Bonadonna RC; Bonora E; Gulli G; Solini A; Shank M; DeFronzo RA
    J Clin Invest; 1993 Feb; 91(2):484-94. PubMed ID: 8432857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glycogen synthase and phosphofructokinase in muscle from type 1 (insulin-dependent) diabetic patients before and after intensive insulin treatment.
    Vestergaard H; Andersen PH; Lund S; Vedel P; Pedersen O
    Diabetologia; 1994 Jan; 37(1):82-90. PubMed ID: 7512060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.